Endoglin is a transmembrane glycoprotein that acts as a co-receptor for transforming growth factor beta (TGF-β) signaling. It plays a critical role in regulating angiogenesis, vascular development, and tissue repair. Dysregulation of endoglin has been implicated in various diseases, including hereditary hemorrhagic telangiectasia (HHT), preeclampsia, and cancer. Research in the area of endoglin focuses on understanding its molecular function, signaling pathways, and potential therapeutic targets for various diseases. Studies also investigate the role of endoglin in vascular biology, tumor angiogenesis, and immune response. Overall, research on endoglin aims to uncover its biological significance and develop novel treatment strategies for associated diseases.